RediNews
ETFs Holding LGND »    LGND Historical Stock Prices »
LGND News Video: Thu, Mar 8, 2018, 1:02 PM — Thursday's ETF Movers: PJP, XME


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Ligand Pharmaceuticals is a biopharmaceutical company focused on developing and acquiring technologies that help pharmaceutical companies discover and develop medicines. Co. has partnerships and license agreements with pharmaceutical and biotechnology companies, and several programs under license with it is in various stages of commercialization and development. Co. has contributed research and technologies for approved medicines that treat cancer, osteoporosis, fungal infections and low blood platelets, among others. Co.'s partners have programs in clinical development targeting seizure, coma, cancer, cardiovascular disease, muscle wasting, liver disease, and kidney disease, among others. Self directed investors in Ligand Pharmaceuticals Inc will be interested in keeping up with all Ligand Pharmaceuticals Inc news they can find, both LGND news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on LGND. At RediNews, we simplify this task by presenting both LGND news releases originating from Ligand Pharmaceuticals Inc itself, and LGND news from a variety of media outlets. Visitors can browse this news online and through our LGND RSS news feed.

LGND News

LGND News — Articles, Videos, & Press Releases

Agios (AGIO) Progressing Well on Pipeline Amid Competition
Thursday, May 24, 2018, 2:18 PM — Zacks
SWTUY or LGND: Which Is the Better Value Stock Right Now?
Thursday, May 24, 2018, 9:18 AM — Zacks
Dr. Reddy's (RDY) Q4 Earnings Fall, Revenues Decline Y/Y
Wednesday, May 23, 2018, 1:05 PM — Zacks
Allergan Stock Down Since Q1 Earnings Report: Here's Why
Wednesday, May 23, 2018, 8:51 AM — Zacks
Inovio Initiates Phase II Study on Pipeline Drug VGX-3100
Tuesday, May 22, 2018, 10:01 AM — Zacks
AstraZeneca's Lokelma Gains FDA Nod to Treat Hyperkalemia
Monday, May 21, 2018, 9:09 AM — Zacks
Pfizer's Epilepsy Drug Lyrica Succeeds in Pediatric Study
Friday, May 18, 2018, 1:21 PM — Zacks
AstraZeneca's (AZN) Q1 Earnings & Sales Miss, Stock Down
Friday, May 18, 2018, 8:06 AM — Zacks
Zoetis (ZTS) Inks Deal to Acquire Abaxis for $2 Billion
Thursday, May 17, 2018, 8:09 AM — Zacks
Amgen's (AMGN) Repatha Gains EU Nod to Include Outcomes Data
Thursday, May 17, 2018, 8:00 AM — Zacks
Sanofi Eczema Drug Dupixent Succeeds in Adolescents Study
Wednesday, May 16, 2018, 9:00 AM — Zacks
Roche's Actemra Gets FDA Nod for Subcutaneous Formulation
Tuesday, May 15, 2018, 8:45 AM — Zacks
Keryx (KERX) Loss Narrower than Expected in Q1, Sales Beat
Friday, May 11, 2018, 3:09 PM — Zacks
Endocyte (ECYT) Q1 Loss Narrower Than Expected, Shares Up
Friday, May 11, 2018, 3:59 AM — Zacks
Valeant (VRX) Rallies on Earnings Beat in Q1, Raises View
Thursday, May 10, 2018, 1:21 PM — Zacks
Xiaflex & Sterile Injectables Drive Endo's (ENDP) Q1 Earnings
Thursday, May 10, 2018, 12:36 PM — Zacks
Catalyst (CPRX) Posts In-Line Q1 Loss, Pipeline Progresses
Thursday, May 10, 2018, 10:35 AM — Zacks
LGND Crosses Above Average Analyst Target
Thursday, May 10, 2018, 10:18 AM — ETF Channel
VIVUS (VVUS) Q1 Loss Narrower Than Expected, Qsymia Falters
Thursday, May 10, 2018, 8:29 AM — Zacks
Puma Biotech (PBYI) Q1 Loss Narrows, Sales Miss, Stock Down
Thursday, May 10, 2018, 7:03 AM — Zacks
Infinity (INFI) Incurs In-Line Loss in Q1, Maintains View
Wednesday, May 9, 2018, 12:12 PM — Zacks
SPDR S&P 600 Small Cap Growth ETF Experiences Big Inflow
Wednesday, May 9, 2018, 10:49 AM — ETF Channel
Epizyme (EPZM) Reports Narrower-Than-Expected Loss in Q1
Wednesday, May 9, 2018, 9:20 AM — Zacks
Ligand (LGND) Beats on Q1 Earnings & Revenues, Keeps View
Wednesday, May 9, 2018, 9:15 AM — Zacks
Theravance Biopharma (TBPH) Q1 Loss Narrows, Sales Up Y/Y
Wednesday, May 9, 2018, 9:03 AM — Zacks
AVEO Pharmaceuticals (AVEO) Q1 Loss Wider Than Expected
Wednesday, May 9, 2018, 8:57 AM — Zacks
Merrimack (MACK) Reports Wider-Than-Expected Loss in Q1
Wednesday, May 9, 2018, 8:49 AM — Zacks
Arena Pharmaceuticals (ARNA) Q1 Loss Wider Than Expected
Wednesday, May 9, 2018, 8:38 AM — Zacks
Jazz Pharmaceuticals (JAZZ) Q1 Earnings, Sales Top Estimates
Wednesday, May 9, 2018, 8:32 AM — Zacks
Agenus' (AGEN) Q1 Loss Wider than Expected, Shares Down
Tuesday, May 8, 2018, 1:59 PM — Zacks
Perrigo (PRGO) Misses on Earnings in Q1, Reiterates View
Tuesday, May 8, 2018, 1:52 PM — Zacks
Agios (AGIO) Q1 Loss Wider than Expected, Revenues Miss
Monday, May 7, 2018, 1:28 PM — Zacks
Alnylam's (ALNY) Q1 Loss Wider than Expected, Sales Miss
Friday, May 4, 2018, 12:35 PM — Zacks
AMAG Pharma (AMAG) Q1 Loss Wider Than Expected, Lifts View
Friday, May 4, 2018, 12:17 PM — Zacks
Emergent (EBS) Misses on Q1 Earnings, Retains 2018 View
Friday, May 4, 2018, 9:50 AM — Zacks
Spectrum (SPPI) Earnings and Sales Beat Estimates in Q1
Friday, May 4, 2018, 9:31 AM — Zacks
Sarepta (SRPT) Q1 Loss Narrows, Exondys 51 Sales Impress
Friday, May 4, 2018, 9:24 AM — Zacks
Immune Design (IMDZ) Posts Narrower-Than-Expected Loss in Q1
Thursday, May 3, 2018, 11:27 AM — Zacks
Conatus' (CNAT) Q1 Loss In Line, Revenues Beat Estimates
Thursday, May 3, 2018, 9:58 AM — Zacks
Acorda (ACOR) Q1 Earnings Miss Estimates, Sales Down Y/Y
Thursday, May 3, 2018, 9:39 AM — Zacks
Bayer (BAYRY) Misses Earnings and Revenue Estimates in Q1
Thursday, May 3, 2018, 8:53 AM — Zacks
What Lies Ahead for Ligand (LGND) This Earnings Season?
Wednesday, May 2, 2018, 9:35 AM — Zacks
Ironwood (IRWD) Incurs Loss in Q1, Announces Restructuring
Wednesday, May 2, 2018, 9:00 AM — Zacks
Novo Nordisk (NVO) Beats Q1 Earnings Estimates, Sales Miss
Wednesday, May 2, 2018, 8:59 AM — Zacks
Zoetis (ZTS) Beats on Q1 Earnings & Sales, Retains '18 View
Wednesday, May 2, 2018, 8:49 AM — Zacks
Allergan (AGN) Q1 Earnings Beat Estimates, Sales Up Y/Y
Monday, April 30, 2018, 9:56 AM — Zacks
Roche (RHHBY) Q1 Earnings: Ocrevus, Perjeta Drive Sales Beat
Friday, April 27, 2018, 11:34 AM — Zacks
Medicines Company's (MDCO) Q1 Loss Widens, Revenues Tank Y/Y
Friday, April 27, 2018, 10:19 AM — Zacks
Alkermes (ALKS) Reports Wider-Than-Expected Loss in Q1
Friday, April 27, 2018, 9:53 AM — Zacks
Shire (SHPG) Q1 Earnings Beat, Rare Disease Franchise Strong
Friday, April 27, 2018, 9:16 AM — Zacks
Sanofi's (SNY) Earnings Beat Estimates in Q1, Sales Miss Mark
Friday, April 27, 2018, 9:04 AM — Zacks
Vertex (VRTX) Q1 Earnings Beat on Strong CF Products Sales
Friday, April 27, 2018, 8:54 AM — Zacks
AbbVie (ABBV) Q1 Earnings Beat, 2018 View Up, Stock Gains
Thursday, April 26, 2018, 10:26 AM — Zacks
BioMarin (BMRN) Q1 Earnings Lower Than Expected, Sales Beat
Thursday, April 26, 2018, 8:30 AM — Zacks
Catalyst Enrolls First Patient in Phase III Firdapse Study
Friday, April 20, 2018, 3:14 PM — Zacks
Bristol-Myers' Opdivo Gets Priority Review for Lung Cancer
Thursday, April 19, 2018, 3:44 PM — Zacks
Calithera's Kidney Cancer Candidate Gets Fast Track Status
Thursday, April 19, 2018, 6:55 AM — Zacks
Bayer to Divest 3.6% Stake to Singapore Company Temasek
Wednesday, April 18, 2018, 4:58 PM — Zacks
Agios' Leukemia Drug Bodes Well for Growth & Strong Pipeline
Wednesday, April 18, 2018, 7:58 AM — Zacks
Alnylam (ALNY) Reports Positive Data for RNAi Candidate
Tuesday, April 17, 2018, 4:35 PM — Zacks
Alkermes Rallies as FDA Accepts NDA for Depression Drug
Tuesday, April 17, 2018, 4:33 PM — Zacks
Merck's Keytruda Betters Survival in Lung Cancer Combo Study
Tuesday, April 17, 2018, 9:13 AM — Zacks
Intercept Reports Phase III Sub-Study Liver Biopsy Data
Monday, April 16, 2018, 3:48 PM — Zacks
Rigel Pharmaceuticals' (RIGL) Stock Gains 16%: Here's Why
Friday, April 13, 2018, 9:51 AM — Zacks
FDA Lifts Clinical Hold on Bellicum's (BLCM) T Cell Therapy
Thursday, April 12, 2018, 9:37 AM — Zacks
Epizyme (EPZM) Publishes Tazemetostat Phase I Data, Stock Up
Wednesday, April 11, 2018, 2:11 PM — Zacks
First Week of November 16th Options Trading For Ligand Pharmaceuticals (LGND)
Wednesday, April 11, 2018, 10:38 AM — Stock Options Channel
Karyopharm's Myeloma Candidate Gets Fast Track Designation
Wednesday, April 11, 2018, 9:56 AM — Zacks
FDA Prolongs Review Date for AbbVie Endometriosis Candidate
Wednesday, April 11, 2018, 9:36 AM — Zacks
5 Best Profitable Stocks Offering Amazing Returns
Wednesday, April 11, 2018, 6:23 AM — Zacks
FDA Restricts Sale of Bayer's Essure Birth Control Device
Tuesday, April 10, 2018, 2:38 PM — Zacks
Ionis (IONS) Clinches Licensing Agreement with AstraZeneca
Tuesday, April 10, 2018, 2:14 PM — Zacks
FDA Okays Label Expansion of Pacira's Exparel's, Stock Up
Monday, April 9, 2018, 3:15 PM — Zacks
Novartis Inks $8.7 Billion Gene Therapy Deal to Buy AveXis
Monday, April 9, 2018, 9:36 AM — Zacks
Clovis Oncology (CLVS) Surges: Stock Moves 5.9% Higher
Monday, April 9, 2018, 6:47 AM — Zacks
Emergent (EBS) Gains 86.1% in a Year's Time: Here's Why
Friday, April 6, 2018, 4:32 PM — Zacks
Novo Nordisk Obtains Licence for Sickle Cell Disease Program
Friday, April 6, 2018, 3:35 PM — Zacks
Sonoma Up on FDA Approval of Antimicrobial Post-Therapy Gel
Friday, April 6, 2018, 8:35 AM — Zacks
Catalyst (CPRX) Up on New Drug Application for Firdapse
Thursday, April 5, 2018, 1:36 PM — Zacks
LGND Crosses Above Average Analyst Target
Thursday, April 5, 2018, 9:12 AM — ETF Channel
Conatus' Emricasan Fails in Phase II Study, Shares Sink
Thursday, April 5, 2018, 8:37 AM — Zacks
Explore Driehaus Strategy With These 5 Momentum Stocks
Thursday, April 5, 2018, 7:49 AM — Zacks
Bio-Path Leukemia Combo Study Shows Positive Early Data
Wednesday, April 4, 2018, 9:15 AM — Zacks
Sanofi's (SNY) Skin Cancer Candidate Filing Accepted in EU
Tuesday, April 3, 2018, 3:28 PM — Zacks
Alkermes Sinks as FDA Refuses Depression Drug Review
Tuesday, April 3, 2018, 1:23 PM — Zacks
EMA Accepts Regeneron/Sanofi's application for Dupixent
Tuesday, April 3, 2018, 9:00 AM — Zacks
Amgen's (AMGN) Xgeva Gets EU Approval for Expanded Label
Tuesday, April 3, 2018, 6:44 AM — Zacks
Edge Therapeutics Loses Edge on Failure of Late-Stage Study
Monday, April 2, 2018, 8:25 AM — Zacks
Amgen's Blincyto Gets FDA Nod for Minimum Residual Disease
Monday, April 2, 2018, 7:56 AM — Zacks
Protagonist Therapeutics Stalls Ulcerative Colitis Study
Tuesday, March 27, 2018, 8:08 AM — Zacks
4 Top-Ranked Drug/Biotech Stocks to Buy as Q1 Nears End
Tuesday, March 27, 2018, 4:13 AM — Zacks
Regeneron Collaborates With Alnylam to Develop NASH Treatment
Thursday, March 22, 2018, 9:42 AM — Zacks
Valeant (VRX) Stock Declines 21% YTD: What Lies Ahead?
Thursday, March 22, 2018, 8:00 AM — Zacks
GlaxoSmithKline Initiates Phase III Combo Study on Benlysta
Wednesday, March 21, 2018, 9:15 AM — Zacks
Novo Nordisk Poised on Strong Pipeline Amid Competition
Wednesday, March 21, 2018, 7:59 AM — Zacks
Ignore Trump's Pricing Rhetoric With These 5 Biotech Picks
Wednesday, March 21, 2018, 6:47 AM — Zacks
Regeneron Eylea Hits 24-Week Primary Endpoint in Study
Tuesday, March 20, 2018, 3:48 PM — Zacks
Heron's Pain Candidate Meets Endpoint in Pivotal Studies
Tuesday, March 20, 2018, 9:49 AM — Zacks
Arena's (ARNA) Etrasimod Meets Phase II Colitis Study Goal
Tuesday, March 20, 2018, 9:43 AM — Zacks
Geron (GERN) Q4 Loss Flat Y/Y, Revenues Surge, Shares Up
Monday, March 19, 2018, 8:18 AM — Zacks
Agenus (AGEN) Q4 Loss Wider Than Expected, Revenues Miss
Friday, March 16, 2018, 8:31 AM — Zacks
Catalyst (CPRX) Posts In-Line Q4 Loss, Pipeline in Progress
Thursday, March 15, 2018, 10:03 AM — Zacks
Arena Pharmaceuticals (ARNA) Q4 Earnings Beat, Sales Down Y/Y
Thursday, March 15, 2018, 8:45 AM — Zacks
Solid Biosciences (SLDB) Hit by Clinical Hold on Lead Drug
Thursday, March 15, 2018, 8:04 AM — Zacks
Epizyme (EPZM) Reports Narrower-than-Expected Loss in Q4
Wednesday, March 14, 2018, 10:00 AM — Zacks
AbbVie's Uterine Fibroids Candidate Succeeds in Phase III
Wednesday, March 14, 2018, 9:15 AM — Zacks
Sarepta to Seek Rapid Approval for Second DMD Drug, Stock Up
Tuesday, March 13, 2018, 9:20 AM — Zacks
Biogen to Buy Mid-Stage Neuropsychiatry Asset From Pfizer
Tuesday, March 13, 2018, 9:09 AM — Zacks
3 Biotech Stocks With Rising Earnings Estimates Post Q4
Tuesday, March 13, 2018, 9:04 AM — Zacks
Merrimack (MACK) Incurs Narrower-Than-Expected Loss in Q4
Tuesday, March 13, 2018, 7:45 AM — Zacks
Aradigm Files MAA for Bronchiectasis Candidate in the EU
Monday, March 12, 2018, 9:25 AM — Zacks
Regeneron and Sanofi Announce Positive Data on Praluent
Monday, March 12, 2018, 7:13 AM — Zacks
Pfizer Gets FDA Panel Backing for New Indication for Xeljanz
Friday, March 9, 2018, 8:22 AM — Zacks
Corcept Plans Korlym Label Expansion, Pipeline in Progress
Thursday, March 8, 2018, 6:24 PM — Zacks
Bayer, BASF in Talks for Vegetable Seeds Business Sell-Off
Thursday, March 8, 2018, 4:59 PM — Zacks
Celldex (CLDX) Q4 Loss Narrows, Revenues Beat, Shares Up
Thursday, March 8, 2018, 9:51 AM — Zacks
Conatus (CNAT) Loss Narrower Than Expected in Q4, Sales Miss
Thursday, March 8, 2018, 9:37 AM — Zacks
Bristol-Myers' Opdivo gets FDA Nod for Every Four Week Dosing
Thursday, March 8, 2018, 5:02 AM — Zacks
Lilly, Boehringer to Expand Jardiance Heart Failure Program
Thursday, March 8, 2018, 5:01 AM — Zacks
Spectrum (SPPI) Q4 Loss Widens Y/Y, Sales Miss, Stock Falls
Wednesday, March 7, 2018, 9:35 AM — Zacks
Dermira's Acne Candidate Fails in Pivotal Trials, Shares Sink
Tuesday, March 6, 2018, 9:36 AM — Zacks
FDA Accepts Regeneron/Sanofi's Dupixent sBLA for Asthma
Monday, March 5, 2018, 3:35 PM — Zacks
Aduro (ADRO) Q4 Loss Narrower Than Expected, Revenues Miss
Monday, March 5, 2018, 9:44 AM — Zacks
Pacira (PCRX) Posts Earnings in Q4, Revenues in Line
Friday, March 2, 2018, 1:33 PM — Zacks
Sarepta (SRPT) Narrows Q4 Loss, Exondys 51 Sales Impress
Friday, March 2, 2018, 1:29 PM — Zacks
Intrexon (XON) Q4 Loss Narrower Than Expected, Revenues Beat
Friday, March 2, 2018, 11:32 AM — Zacks
Perrigo (PRGO) Surpassed Earnings in Q4, Revenues Down Y/Y
Friday, March 2, 2018, 11:12 AM — Zacks
Puma (PBYI) Q4 Loss Narrower Than Expected, Shares Down
Friday, March 2, 2018, 10:37 AM — Zacks
Impax (IPXL) Q4 Earnings & Revenues Miss Estimates, Fall Y/Y
Friday, March 2, 2018, 9:53 AM — Zacks
Jazz Pharmaceuticals (JAZZ) Q4 Earnings Miss, Sales Up Y/Y
Wednesday, February 28, 2018, 8:29 AM — Zacks
AMAG Pharma (AMAG) Beats on Q4 Earnings, Misses on Revenues
Wednesday, February 28, 2018, 8:09 AM — Zacks
Ligand Pharmaceuticals Larger Than S&P 500 Component Range Resources
Thursday, February 22, 2018, 4:50 PM — Market News Video
Ligand (LGND) Q4 Earnings & Revenues Top, 2018 View Solid
Thursday, February 22, 2018, 9:17 AM — Zacks
What's in Store for Ligand (LGND) This Earnings Season?
Monday, February 19, 2018, 9:10 AM — Zacks
Ligand Pharmaceuticals Reaches Analyst Target Price
Tuesday, February 13, 2018, 9:31 AM — ETF Channel
Ligand Pharmaceuticals Reaches Analyst Target Price
Friday, January 12, 2018, 9:24 AM — ETF Channel
RSI Alert: Ligand Pharmaceuticals (LGND) Now Oversold
Monday, November 20, 2017, 12:04 PM — Dividend Channel
LGND Crosses Above Average Analyst Target
Wednesday, November 15, 2017, 9:00 AM — ETF Channel
Strange: Bullish LGND Analysts Actually See -1.3% Downside
Friday, November 3, 2017, 10:03 AM — ETF Channel
LGND Crosses Above Average Analyst Target
Wednesday, October 4, 2017, 9:18 AM — ETF Channel
Noteworthy Wednesday Option Activity: CLF, LGND, ZION
Wednesday, September 27, 2017, 3:39 PM — Stock Options Channel
The LGND Paradox: Analysts Bullish But Forecast -1.71% Fall
Friday, September 8, 2017, 9:22 AM — ETF Channel
LGND is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

ARQL News
CRTX News
STAA News
BABY News
MDXG News
CMN News
MDCO News
CYTX News
ACOR News
TSRO News

RediNews would like to be your web content provider of choice for news feeds by stock ticker symbol, or by market sector. An ideal complement to other financial content like stock quotes and charts, our news gives your users what they want — to see what is being published about the stocks they own, and what the companies themselves are publishing. Simply navigate to any RediNews news page by specific ticker symbol, then click the RSS icon for any news page to reach the associated RSS feed (the icon will look like this): . There is no charge to use our feeds, they are available to you for free.

LGND News | www.RediNews.com | Copyright © 2013 - 2018, All Rights Reserved

Nothing in www.RediNews.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.